Haematologica 2020 Feb 6
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Related Questions
New answer by at Baylor College of Medicine (April 6, 2021)
Great question. The answer is kind of. The COG studies AAML03P1 and AAML0531 gave 5 chemotherapy cycles to patients who did not go to transplant in first remission, but we kno...